A federal advisory committee met earlier this month and recommended the approval of two new cholesterol-lowering drugs that could significantly change the way doctors treat patients with high cholesterol levels. KUTV 2 meets with Max, a patient with high cholesterol who is unable to take statins and Brent Muhlestein, MD, cardiologist at the Intermountain Medical Center Heart Institute.

свернуть